In CKD stage 5D patients (S2 Table), male gender, hemodialysis as modality, history of cardiovascular disease (CVD), higher age and phosphate and lower bicarbonate, PTH (both assays), residual renal function, and blood platelets all were significantly associated with higher serum sclerostin levels. This evidence concerns the gene PTH and chronic kidney disease.